Collections in this community

Recent Submissions

1. Data-driven, cross-disciplinary collaboration: lessons learned at the largest academic health center in Latin America during the COVID-19 pandemic

   FRONTIERS IN PUBLIC HEALTH, v.12, article ID 1369129, 15p, 2024

   Introduction The COVID-19 pandemic has prompted global research efforts to reduce infection impact, highlighting the potential of cross-disciplinary collaboration to enhance research quality and efficiency.Methods At the FMUSP-HC academic health system, we implemented innovative flow management r...

2. Frequency of Human Papillomavirus Detection in Chagasic Megaesophagus Associated or Not with Esophageal Squamous Cell Carcinoma

   PATHOBIOLOGY, v.89, n.1, p.29-37, 2022

   Background: Chagasic megaesophagus (CM) as well as the presence of human papillomavirus (HPV) has been reported as etiological factors for esophageal squamous cell carcinoma (ESCC). Objective: We assessed the prevalence of HPV DNA in a series of ESCCs associated or not with CM. Data obtained were...

3. Locking and Unlocking Thrombin Function Using Immunoquiescent Nucleic Acid Nanoparticles with Regulated Retention In Vivo

   NANO LETTERS, v.22, n.14, p.5961-5972, 2022

   The unbalanced coagulation of blood is a life-threatening event that requires accurate and timely treatment. We introduce a user-friendly biomolecular platform based on modular RNA-DNA anticoagulant fibers programmed for reversible extracellular communication with thrombin and subsequent control ...

4. Protein Disulfide Isomerase overexpression induces mitochondrial reorganization and a differentiated VSMC phenotype: role of mitofusin-2

   FREE RADICAL BIOLOGY AND MEDICINE, v.208, suppl.1, p.S98-S98, 2023

5. Five-Year Survival in Patients with ES-SCLC Treated with Atezolizumab in IMpower133: Imbrella a Extension Study Results

   JOURNAL OF THORACIC ONCOLOGY, v.18, n.11, suppl.S, p.S44-S45, 2023

6. Canakinumab with Standard of Care for Patients with Advanced NSCLC: T-cell Infiltration Analysis in CANOPY-1

   JOURNAL OF THORACIC ONCOLOGY, v.18, n.11, suppl.S, p.S313-S313, 2023

7. AVANZAR: Phase III Study of Datopotamab Deruxtecan (Dato-DXd) plus Durvalumab plus Carboplatin as 1L Treatment of Advanced/mNSCLC

   JOURNAL OF THORACIC ONCOLOGY, v.18, n.11, suppl.S, p.S305-S306, 2023

8. A Phase II Trial of JDQ443 in <i>KRAS G12C</i>-Mutated NSCLC with PD-L1 Expression &lt;1% or PD-L1 Expression ≥1% and an <i>STK11</i> Co-Mutation

   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, v.118, n.1, p.E13-E14, 2024

9. Real-world clinical characteristics and treatment (tx) outcomes by co-mutation status in patients (pts) with <i>KRAS G12C</i>- mutated non-small cell lung cancer (NSCLC)

   CANCER RESEARCH, v.83, n.7, suppl.S, 2023

10. Sympathetic Neural Overdrive, Endothelial Dysfunction and Aortic Stiffness in Coronavirus Disease 2019 Survivors: A Short-Term Study of Cardiovascular Sequelae

    CIRCULATION, v.144, suppl.1, 2021